James S. O’Donnell

12.2k citations
225 papers · 7.5k · 2 hit papers · h-index 42

Impact in

  • Hematology top 0.1%
    • Platelet Disorders and Treatments
    • Blood groups and transfusion
    • Blood Coagulation and Thrombosis Mechanisms
    • Hemophilia Treatment and Research
  • Internal Medicine top 0.5%
    • Venous Thromboembolism Diagnosis and Management

Papers in

  • Hematology 132
    • Platelet Disorders and Treatments 84
    • Blood groups and transfusion 43
    • Blood Coagulation and Thrombosis Mechanisms 41
    • Hemophilia Treatment and Research 31
  • Immunology 41
    • Complement system in diseases 33
Co-authors
Michael Laffan (18 shared papers)P. Vincent Jenkins (16 shared papers)Jamie M. O’Sullivan (41 shared papers)Roger J. S. Preston (50 shared papers)Dennis McGonagle (5 shared papers)Charlie Bridgewood (4 shared papers)Κassem Sharif (3 shared papers)Richard A. Manning (8 shared papers)
Journals
Blood (33 papers)British Journal of Haematology (19 papers)Journal of Thrombosis and Haemostasis (19 papers)Haemophilia (17 papers)Blood Advances (8 papers)
Partner nations
IrelandUnited KingdomUnited States

In The Last Decade

James S. O’Donnell

213 papers receiving 7.4k citations

James S. O’Donnell's Hit Papers

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease 2021 · 300 citations
3000+2+4Years since publication100200300400500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2021 Blood Advances
  2. 2020 The Lancet Rheumatology

Peers

James S. O’Donnell
Comparison fields: 5 of 141
  • Hematology 3.5k
  • Internal Medicine 708
  • Genetics 728
  • Neurology 866
  • Infectious Diseases 897
Replace Shoshana Revel‐Vilk with:
Shoshana Revel‐Vilk Israel
Thomas Lecompte France
Craig M. Kessler United States
Marilyn J. Manco‐Johnson United States
Owen Smith Ireland
Philippe de Moerloose Switzerland
C. Erik Hack Netherlands
Flora Peyvandi Italy
Louis M. Aledort United States
George M. Rodgers United States
James S. O’Donnell relative to Shoshana Revel‐Vilk Israel Shoshana Revel‐Vilk's profile →
Citations per field
00.5×2×2.8×
Shoshana Revel‐Vilk · 1×
Citations per year

Countries citing papers authored by James S. O’Donnell

Since Specialization
Citations

This map shows the geographic impact of James S. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. O’Donnell more than expected).

Fields of papers citing papers by James S. O’Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. O’Donnell. The network helps show where James S. O’Donnell may publish in the future.

Co-authors

The 25 scholars most cited alongside James S. O’Donnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James S. O’Donnell Line = papers co-authored together James S. O’Donnell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 225 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
The Lancet Rheumatology ·Dennis McGonagle, James S. O’Donnell, Κassem Sharif, Paul Emery, Charlie Bridgewood
Hit paper breakdown →		2020548
2
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
Neurology ·John Flibotte, N. Hagan, James S. O’Donnell, Steven M. Greenberg, Jonathan Rosand
2004465
3
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Transfusion ·P. Vincent Jenkins, James S. O’Donnell
2006306
4
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
Blood Advances ·Paula James, Nathan T. Connell, Barbara Ameer, Jorge Di Paola, Jeroen Eikenboom, Nicolas Giraud, Sandra L. Haberichter, Vicki Jacobs-Pratt, Barbara A. Konkle, Claire McLintock, Simon McRae, Robert R. Montgomery, James S. O’Donnell, Nikole Scappe, Robert F. Sidonio, Veronica H. Flood, Nedaa Husainat, Mohamad A. Kalot, Reem A. Mustafa
Hit paper breakdown →		2021300
5
COVID19 coagulopathy in Caucasian patients
British Journal of Haematology ·Helen Fogarty, Liam Townsend, Clíona Ní Cheallaigh, Colm Bergin, Ignacio Martín‐Loeches, Paul Browne, Christopher L. Bacon, Richard Gaule, Alexander Gillett, Mary Byrne, Kevin M. Ryan, Niamh O’Connell, Jamie M. O’Sullivan, Niall Conlon, James S. O’Donnell
2020278
6
The relationship between ABO histo‐blood group, factor VIII and von Willebrand factor
Transfusion Medicine ·James S. O’Donnell, Michael Laffan
2001241
7
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology
British Journal of Haematology ·(unknown), Will Lester, James S. O’Donnell, Andrew Will, Robert C. Tait, Anne Goodeve, Carolyn M. Millar, David Keeling
2014238
8
Elevated factor VIII levels and risk of venous thrombosis
British Journal of Haematology ·P. Vincent Jenkins, Orla Rawley, Owen Smith, James S. O’Donnell
2012213
9
Proteolytic inactivation of ADAMTS13 by thrombin and plasmin
Blood ·James T. B. Crawley, Jonathan Lam, James B. Rance, Luigina Mollica, James S. O’Donnell, David A. Lane
2004177
10
High Prevalence of Elevated Factor VIII Levels in Patients Referred for Thrombophilia Screening: Role of Increased Synthesis and Relationship to the Acute Phase Reaction
Thrombosis and Haemostasis ·James S. O’Donnell, Edward G. D. Tuddenham, Richard A. Manning, Geoffrey Kemball‐Cook, David W. Johnson, Michael Laffan
1997175
11
Bleeding symptoms and coagulation abnormalities in 337 patients with AL‐amyloidosis
British Journal of Haematology ·Andrew Mumford, James S. O’Donnell, Julian D. Gillmore, Richard A. Manning, Philip N. Hawkins, Michael Laffan
2000149
12
Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance
Haemophilia ·Virginie Terraube, James S. O’Donnell, P. Vincent Jenkins
2009126
13
Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response
Journal of Thrombosis and Haemostasis ·Liam Townsend, Helen Fogarty, Adam H. Dyer, Ignacio Martín‐Loeches, Ciarán Bannan, Parthiban Nadarajan, Colm Bergin, Cliona O’Farrelly, Niall Conlon, Nollaig M. Bourke, Soracha E. Ward, Mary Byrne, Kevin M. Ryan, Niamh O’Connell, Jamie M. O’Sullivan, Clíona Ní Cheallaigh, James S. O’Donnell
2021125
14
Amount of H Antigen Expressed on Circulating von Willebrand Factor Is Modified by ABO Blood Group Genotype and Is a Major Determinant of Plasma von Willebrand Factor Antigen Levels
Arteriosclerosis Thrombosis and Vascular Biology ·James S. O’Donnell, Frank Boulton, Richard A. Manning, Michael Laffan
2002111
15
von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation
British Journal of Haematology ·Martine J. Hollestelle, Cynthia Donkor, Ebenezer Akrofi Mantey, Srabasti J. Chakravorty, Alister Craig, Alex Osei‐Akoto, James S. O’Donnell, Jan A. van Mourik, James Bunn
2006107
16
Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation
Blood ·Fionnuala Ní Áinle, Roger J. S. Preston, P. Vincent Jenkins, Hendrik J. Nel, Jennifer Johnson, Owen Smith, Barry White, Padraic G. Fallon, James S. O’Donnell
2009106
17
Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels
Blood ·Michelle Lavin, Sonia Águila, Sonja Schneppenheim, Niall Dalton, Kenneth L. Jones, Jamie M. O’Sullivan, Niamh O’Connell, Kevin M. Ryan, Barry White, Mary Byrne, Marie Rafferty, Mairead M. Doyle, Margaret Nolan, Roger J. S. Preston, Ulrich Budde, Paula James, Jorge Di Paola, James S. O’Donnell
201799
18
Severe Plasmodium falciparum Malaria Is Associated with Circulating Ultra-Large von Willebrand Multimers and ADAMTS13 Inhibition
PLoS Pathogens ·Deirdre Larkin, Bas de Laat, P. Vincent Jenkins, James Bunn, Alister Craig, Virginie Terraube, Roger J. S. Preston, Cynthia Donkor, Georges E. Grau, Jan A. van Mourik, James S. O’Donnell
200998
19
Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings
Blood ·Daniel J. Bridges, James Bunn, Jan A. van Mourik, Georges E. Grau, Roger J. S. Preston, Malcolm E. Molyneux, Valéry Combes, James S. O’Donnell, Bas de Laat, Alister Craig
200997
20
The relationship between ABO blood group, von Willebrand factor, and primary hemostasis
Blood ·Soracha E. Ward, Jamie M. O’Sullivan, James S. O’Donnell
202091

About James S. O’Donnell

James S. O’Donnell is a scholar working on Hematology, Immunology, Surgery, Internal Medicine and Cardiology and Cardiovascular Medicine, having authored 225 papers that have together received 7.5k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (84 papers), Blood groups and transfusion (43 papers), Blood Coagulation and Thrombosis Mechanisms (41 papers), Complement system in diseases (33 papers), Hemophilia Treatment and Research (31 papers), Venous Thromboembolism Diagnosis and Management (26 papers), Heparin-Induced Thrombocytopenia and Thrombosis (14 papers) and Atrial Fibrillation Management and Outcomes (13 papers). The work is most often cited by research in Hematology (3.5k citations), Internal Medicine (708 citations), Genetics (728 citations), Neurology (866 citations) and Infectious Diseases (897 citations). James S. O’Donnell has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Michael Laffan, P. Vincent Jenkins, Jamie M. O’Sullivan, Roger J. S. Preston, Dennis McGonagle, Charlie Bridgewood, Κassem Sharif, Richard A. Manning, Paul Emery and Owen Smith. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Thrombosis and Haemostasis, Haemophilia and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoshana Revel‐VilkBreakdown of academic impact, for papers by Thomas LecompteBreakdown of academic impact, for papers by Craig M. KesslerBreakdown of academic impact, for papers by Marilyn J. Manco‐JohnsonBreakdown of academic impact, for papers by Owen SmithBreakdown of academic impact, for papers by Philippe de MoerlooseBreakdown of academic impact, for papers by C. Erik HackBreakdown of academic impact, for papers by Flora PeyvandiBreakdown of academic impact, for papers by Louis M. AledortBreakdown of academic impact, for papers by George M. Rodgers